Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: A randomized controlled trial

American Heart Journal

Volumn 151, Issue 2, 2006, Pages 380-389

  Klein, Allan L ^a   Grimm, Richard A ^a   Jasper, Susan E ^a   Murray, R Daniel ^a   Apperson Hansen, Carolyn ^a   Lieber, Elizabeth A ^a   Black, Ian W ^b   Davidoff, Ravin ^c   Erbel, Raimund ^d   Halperin, Jonathan L ^e   Orsinelli, David A ^f   Porter, Thomas R ^g   Stoddard, Marcus F ^h  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MANLY HOSPITAL   (Australia)

^c BOSTON MEDICAL CENTER   (United States)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^h UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBOLISM; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; EMBOLISM; FEMALE; HEMORRHAGE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 31444443926     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.07.011     Document Type: Article

References (26)

1. V. Fuster, L.E. Ryden, and R.W. Asinger ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology J Am Coll Cardiol 38 2001 1231 1266
2. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
3. C.J. Bjerkelund, and O.M. Orning The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation Am J Cardiol 23 1969 208 216
4. B. Stein, J.L. Halperin, and V. Fuster Should patients with atrial fibrillation be anticoagulated prior to and chronically following cardioversion? Cardiovasc Clin 21 1990 231 247
5. R.A. Grimm, W.J. Stewart, and I.W. Black Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation? J Am Coll Cardiol 23 1994 533 541
6. D.E. Singer, G.W. Albers, and J.E. Dalen Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 429S 456S
7. A.L. Klein, R.D. Murray, and R.A. Grimm Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation J Am Coll Cardiol 37 2001 691 704
8. W.J. Manning, D.I. Silverman, and S.P. Gordon Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi N Engl J Med 328 1993 750 755
9. D.I. Silverman, and W.J. Manning Role of echocardiography in patients undergoing elective cardioversion of atrial fibrillation Circulation 98 1998 479 486
10. A.L. Klein, R.A. Grimm, and R.D. Murray Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation N Engl J Med 344 2001 1411 1420
11. Steering and Publications Committees of the ACUTE study Design of a clinical trial for the assessment of cardioversion using transesophageal echocardiography (the ACUTE multicenter study) Am J Cardiol 81 1998 877 883
12. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham study Stroke 22 1991 983 988
13. S.S. Chugh, J.L. Blackshear, and W.K. Shen Epidemiology and natural history of atrial fibrillation: clinical implications J Am Coll Cardiol 37 2001 371 378
14. A.L. Klein, R.D. Murray, and R.A. Grimm Bleeding complications in patients with atrial fibrillation undergoing cardioversion randomized to transesophageal echocardiographically guided and conventional anticoagulation therapies Am J Cardiol 92 2003 161 165
15. S.A. Tejan-Sie, R.D. Murray, and I.W. Black Spontaneous conversion of patients with atrial fibrillation scheduled for electrical cardioversion: an ACUTE trial ancillary study J Am Coll Cardiol 42 2003 1638 1643
16. M.J. Weigner, L.R. Thomas, and U. Patel Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: short-term safety and impact on maintenance of sinus rhythm at 1 year Am J Med 110 2001 694 702
17. D.G. Wyse, A.L. Waldo, and J.P. DiMarco A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
18. D.G. Wyse Rhythm management in atrial fibrillation: less is more J Am Coll Cardiol 41 2003 1703 1706
19. S.H. Hohnloser, K.H. Kuck, and J. Lilienthal Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial Lancet 356 2000 1789 1794
20. I.C. Van Gelder, V.E. Hagens, and H.A. Bosker A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
21. J. Carlsson, S. Miketic, and J. Windeler Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study J Am Coll Cardiol 41 2003 1690 1696
22. C.A. Asher, and A.L. Klein Transesophageal echocardiography in patients with atrial fibrillation Pacing Clin Electrophysiol 26 2003 1597 1603
23. G. Corrado, S. Beretta, and L. Sormani Prevalence of atrial thrombi in patients with atrial fibrillation/flutter and subtherapeutic anticoagulation prior to cardioversion Eur J Echocardiogr 5 2004 257 261
24. R.D. Murray, A. Shah, and S.E. Jasper Transesophageal echocardiography guided enoxaparin antithrombotic strategy for cardioversion of atrial fibrillation: the ACUTE II pilot study Am J Heart 139 2000 1 7
25. A.L. Klein, S.E. Jasper, and C. Apperson-Hansen Safety and efficacy of enoxaparin compared with unfractionated heparin strategy for cardioversion of atrial fibrilliation using transesophageal echochardiology: preliminary results from the Assessment of Cardioversion Using Transesophageal Echocardiology (ACUTE) II Study Circulation 112 2005 (abstract)
26. C. Stellbrink, U. Nixdorff, and T. Hofmann Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial Circulation 109 2004 997 1003